Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience

Authors

Institutions

Publication Details

Journal
Endocrine
Published
2024-10-05
DOI
https://doi.org/10.1007/s12020-024-04029-2
Citations
1
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience

David Tak Wai Lui, Kimberly Hang Tsoi, Nancy Su Jiang, Carol Ho Yi Fong et al.
1 citations
Endocrine
Pharmacology and Obesity Treatment
0.45
article

Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience

David Tak Wai Lui, Kimberly Hang Tsoi, Nancy Su Jiang, Carol Ho Yi Fong, Michele Mae Ann Yuen, Wing Chow
article en
1 citations

Abstract

No abstract available for this paper.
EndocrineVol. 87(2)
Chinese University of Hong Kong (HK), University of Hong Kong (HK)
Good health and well-being
Openalex Percentile: Top 31%
Pharmacology and Obesity Treatment
0.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experience — David Tak Wai Lui, Kimberly Hang Tsoi, et al. · Endocrine (2024) | TGRS Research Map | TGRS